9323 Open-label Results From Grace, A Phase 3 Double-blind, Randomized-withdrawal Study Of The Selective Glucocorticoid Receptor Modulator Relacorilant For The Treatment Of Endogenous Hypercortisolism (Cushing Syndrome)
Sign Up to like & getrecommendations! Published in 2024 at "Journal of the Endocrine Society"
DOI: 10.1210/jendso/bvae163.1287
Abstract: Abstract Disclosure: R. Pivonello: Consulting Fee; Self; Corcept Therapeutics, Recordati AG, Crinetics Pharmaceuticals, H. Lundbeck A/S. Other; Self; Corcept- Research Funding, Neurocrine Biosciences- Research Funding, Recordati AG- Research Funding, Strongbridge Biopharma- Research Funding. G. Arnaldi:… read more here.
Keywords: corcept therapeutics; board member; research; member self ... See more keywords
MON-302 The Design of MOMENTUM: A Prospective Study of the Prevalence of Endogenous Hypercortisolism in Individuals With Resistant Hypertension
Sign Up to like & getrecommendations! Published in 2025 at "Journal of the Endocrine Society"
DOI: 10.1210/jendso/bvaf149.782
Abstract: Abstract Disclosure: J. Plutzky: Altimmune, Amgen Inc, Boehringer Ingelheim, Corcept Therapeutics, New Amsterdam, Novo Nordisk, Toku Eyes, Esperion, Novartis Pharmaceuticals. R.J. Auchus: Neurocrine Biosciences/Neurocrine UK, LTD, Spruce Biosciences, Corcept Therapeutics, Crinetics Pharmaceuticals, Recordati Rare Diseases,… read more here.
Keywords: corcept therapeutics; novo nordisk; novartis pharmaceuticals; ehc ... See more keywords
SUN-463 Efficacy and Safety of Relacorilant in Individuals With Adrenal Hypercortisolism: Results From the Phase 3 GRACE and GRADIENT Studies
Sign Up to like & getrecommendations! Published in 2025 at "Journal of the Endocrine Society"
DOI: 10.1210/jendso/bvaf149.882
Abstract: Abstract Disclosure: U. Dischinger: Recordati, Novo Nordisk, Alnylam, Merck. A. Al-Karadsheh: None. C. Badiu: Corcept Therapeutics, Lundbeck, Novo Nordisk, Ipsen, Merck, Pfizer, Inc. F. Ceccato: Novartis Pharmaceuticals, HRA Pharmaceuticals, Novo Nordisk, Recordati. H. East: Corcept… read more here.
Keywords: corcept therapeutics; novo nordisk; none; gradient ... See more keywords
MON-572 Characterization of Individuals With Difficult-to-Control Type 2 Diabetes and Post-Dexamethasone Suppression Test Cortisol Values 1.8 µg/dL: Findings From the CATALYST Part 1 Study
Sign Up to like & getrecommendations! Published in 2025 at "Journal of the Endocrine Society"
DOI: 10.1210/jendso/bvaf149.938
Abstract: Abstract Disclosure: R.J. Auchus: Neurocrine Biosciences/Neurocrine UK, LTD, Spruce Biosciences, Corcept Therapeutics, Crinetics Pharmaceuticals, Recordati Rare Diseases, Adrenas Therapeutics, Mineralys Pharmaceuticals, Quest Diagnostics, Xeris Pharmaceuticals, Novo Nordisk, H Lundbeck A/S, Sparrow Pharmaceuticals, Astellas Pharmaceuticals, Acerand… read more here.
Keywords: corcept therapeutics; novo nordisk; dst cortisol; inc ... See more keywords